http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104603153-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-3204
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-3274
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-3809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-286
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-3217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K17-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
filingDate 2013-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104603153-B
titleOfInvention Carrier, its preparation method and its application for antibody purification
abstract It is an object of the invention to provide the preparation method of the carrier for being fixed with albumin A thereon and the carrier, the albumin A has permission antibody, and many antibody need not be subjected to the specific amino acid sequence desorbed under the gentle pH conditions (specifically, pH 4.0 to 5.5) of acid modification wherein;And the preparation method of the carrier.A kind of fixation support (not including having integrally-built fixation support), is adsorbed with albumen, the albumen is by passing through formula by electrostatic interaction thereon:The amino acid sequence composition that R1 R2 R3 R4 R5 R6 are represented, wherein be used to be fixed on fixation support by the R1 R2 R3 parts represented, wherein:The sequence represents the sequence from amino terminal side to carboxyl terminal side;The sequence of R2 parts is the sequence of the albumin A mutant as the albumen for waiting to be fixed, or the sequence that 1 to 3 unit of the wherein sequence of albumin A mutant is joined together, the albumin A mutant have combined strongly with antibody in neutral conditions and under pH 4.0 to 5.5 solutions of weak acidity with the characteristic of the antibody dissociation combined in neutral conditions.
priorityDate 2012-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451774801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419576385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397808
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20574727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457788441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157683664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457585837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71380394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409206349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415791318
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451210943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20192691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421922341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547014
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447650953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426383730
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6992103

Total number of triples: 75.